Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465575) titled 'Berberine Phytosome for Signs and Symptoms of Polycystic Ovary Syndrome (PCOS)' on March 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Liaquat University of Medical & Health Sciences

Condition: Polycystic Ovary Syndrome

Intervention: Dietary Supplement: Berberine Phytosome (Sophy(R))

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 16, 2026

Target Sample Size: 150

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials....